ArticleBiotechnology letters2026
Heterologous expression of active xanthine oxidase from Cellulosimicrobium sp. TH20 in Escherichia coli.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Active bacterial xanthine oxidase (XOD) has not been functionally expressed in Escherichia coli, limiting protein engineering of this industrial molybdoflavoprotein. Here, the first production of active XOD from Cellulosimicrobium sp. TH20 in E. coli BW25113 is reported. The key factor was identified as the plasmid pBADp15, combining a low-copy P15A origin with the tightly regulated araBAD promoter, with which an enzymatic activity of 0.2 U/mL was obtained-a 6.7-fold improvement over the high-copy vector pBAD18. Activity was completely abolished upon deletion of xodC from the expression cassette, consistent with its established role as an essential maturation chaperone. The purified enzyme exhibited a specific activity of 8.0 U/mg, a K
Indexed as
Identifiers
42821021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.